carbonthatcarbonthat
← Every company

Emergent BioSolutions Inc Insider Trading

Every director, officer and 10% holder of Emergent BioSolutions Inc has to report each trade in its stock within two business days of making it. This is those filings.

EBS on carbonthat →
Insiders filing
2
3 reported lines
Open-market buys
0
Open-market sales
3
$171K
Net
$171K
sold more

Purchases and sales

Open-market trades only — the lines where someone chose to buy or sell at the going price.

InsiderActionValue
Donald W DeGolyerDirector2026-10-0717.8K shat $7.09
Sale10b5-1 plan
$126.2K
Paul Anthony WilliamsSVP, Products Business2026-10-013K shat $6.53
Sale10b5-1 plan
$19.6K
Paul Anthony WilliamsSVP, Products Business2026-07-013K shat $8.40
Sale10b5-1 plan
$25.2K

Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.

More on EBS

Company overviewEverything on EBS in one place, with the price.SEC filingsWhat EBS's 8-Ks say happened: results, departures, auditor changes.Planned salesSales EBS insiders have filed notice of.Who owns itEvery manager reporting a position in EBS.Funds holding itWhich funds and ETFs hold EBS, and how big a bet.LobbyingWhat EBS spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on EBS's account, and who they worked for.Federal contractsWhat federal agencies pay EBS.

Follow Emergent BioSolutions Inc (EBS) by email

New trades in Emergent BioSolutions Inc (EBS) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets

PeopleCEOs, investors, public officials and market commentators.SEC FilingsAuditor changes, restatements, departures and results, from 8-Ks.Insider BuyingCluster buys, and chief executives buying their own stock.The InsidersOne page per filer: every company they file against.